|
HGSNAT expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.591900E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.708300E-02 |
| Normal-vs-Stage2 |
8.484400E-01 |
| Normal-vs-Stage3 |
5.889500E-02 |
| Normal-vs-Stage4 |
1.458150E-02 |
| Stage1-vs-Stage2 |
1.460240E-01 |
| Stage1-vs-Stage3 |
8.367400E-01 |
| Stage1-vs-Stage4 |
2.476400E-01 |
| Stage2-vs-Stage3 |
1.727620E-01 |
| Stage2-vs-Stage4 |
5.084300E-02 |
| Stage3-vs-Stage4 |
3.980800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.270200E-02 |
| Normal-vs-AfricanAmerican |
5.446200E-04 |
| Normal-vs-Asian |
3.192000E-02 |
| Caucasian-vs-AfricanAmerican |
2.861700E-02 |
| Caucasian-vs-Asian |
5.480200E-01 |
| AfricanAmerican-vs-Asian |
1.279600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.273040E-01 |
| Normal-vs-Female |
2.365900E-02 |
| Male-vs-Female |
6.720200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.373700E-02 |
| Normal-vs-Age(41-60Yrs) |
4.787800E-02 |
| Normal-vs-Age(61-80Yrs) |
5.213600E-01 |
| Normal-vs-Age(81-100Yrs) |
3.610800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.245800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.103170E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.762800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.052800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.715800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.443400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.719200E-01 |
| Classical-VS-Follicular |
7.77529995943382E-09 |
| Classical-VS-Other |
2.205200E-01 |
| Classical-VS-Normal |
2.059300E-03 |
| Tall-VS-Follicular |
2.214700E-04 |
| Tall-VS-Other |
1.890560E-01 |
| Tall-VS-Normal |
1.110390E-02 |
| Follicular-VS-Other |
4.857600E-01 |
| Follicular-VS-Normal |
1.550810E-01 |
| Other-VS-Normal |
9.607200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.847000E-01 |
| Normal-vs-N1 |
6.435800E-03 |
| N0-vs-N1 |
2.206100E-02 |
|
|
